Lauren Dembeck, PhD

Lauren Dembeck, PhD

Lauren Dembeck, PhD, is a freelance science & medical writer.

Articles by Lauren Dembeck, PhD

Lauren Dembeck, PhDGenetics & Breast Cancer | July 16, 2025
HER2DX predicts outcomes in early HER2+ breast cancer, adding prognostic value beyond standard clinical-pathologic factors.
Lauren Dembeck, PhDObesity | July 16, 2025
Amycretin shows significant weight loss and tolerability in early trial, supporting further study for obesity treatment.
Lauren Dembeck, PhDGastroenterology | July 15, 2025
A new lifestyle-based GERD Risk Scoring System shows high accuracy in identifying at-risk individuals for early intervention.
Lauren Dembeck, PhDIBS | July 14, 2025
New research shows stem cell-derived apoptotic vesicles may ease IBS by restoring brain-gut balance via the 5-HT pathway.
Lauren Dembeck, PhDAsthma | July 14, 2025
AI and graph models reveal how Suhuang herbs target lung tissues, blending TCM theory with molecular science.
Lauren Dembeck, PhDColon Polyps | July 14, 2025
Rising colorectal cancer rates in young adults highlight the urgent need for precise screening and polyp management.
Lauren Dembeck, PhDIBS | July 14, 2025
Social media offers key insights into IBS lived experiences, highlighting patient needs, support, and care gaps.
Lauren Dembeck, PhDPulmonology | July 10, 2025
Ensifentrine offers a novel, inhaled option to improve COPD symptoms in patients not controlled on dual bronchodilators.
Lauren Dembeck, PhDHead and Neck Cancer | July 8, 2025
Researchers identified 4 genes tied to propionate metabolism to predict head and neck cancer risk and survival.
Lauren Dembeck, PhDNeurodivergent | July 8, 2025
Nutritional epigenetics may help prevent autism and ADHD via maternal diet changes.
Lauren Dembeck, PhDIBD | July 3, 2025
A four-strain probiotic is safe and shows symptom relief trend in patients with IBD/IBS overlap, study shows.
Lauren Dembeck, PhDIBD | July 3, 2025
Steroids and comorbidities—not IBD itself—drive pneumonia risk in IBD, study finds.
Lauren Dembeck, PhDBreast Cancer News | June 27, 2025
FDA authorizes CLAIRITY BREAST, the first AI tool to predict 5-year breast cancer risk from screening mammograms.
Lauren Dembeck, PhDMelanoma | June 27, 2025
NF1-mutant melanoma may respond to EGFR inhibitors, offering hope for patients resistant to immunotherapy.
Lauren Dembeck, PhDPulmonology | June 26, 2025
Digital inhaler data may predict COPD exacerbations up to 14 days early, offering a potential remote monitoring tool.
Lauren Dembeck, PhDType 2 Diabetes | June 25, 2025
Lifestyle and metformin interventions cut diabetes risk for 21 years in adults with prediabetes, DPP study shows.
Lauren Dembeck, PhDObesity | June 24, 2025
Black youth with dysglycemia show reduced insulin clearance, possibly contributing to β-cell dysfunction and ...
Lauren Dembeck, PhDObesity | June 19, 2025
Real-world weight loss with semaglutide or tirzepatide is lower due to early discontinuation and low maintenance dosing.
Lauren Dembeck, PhDTriple-Negative Breast Cancer | June 4, 2025
Sacituzumab + pembrolizumab improves PFS vs chemo in PD-L1+ TNBC, per ASCENT-04/KEYNOTE-D19 phase 3 trial at ASCO 2025.
Lauren Dembeck, PhDHR Breast Cancer | June 3, 2025
Elinzanetant reduces vasomotor symptoms from endocrine therapy in HR+ breast cancer, with rapid onset and good tolerability.